JACQUELYN DELGADO: Open Payments
NPI 1952775124 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,339 in 74 payments from 12 companies in 2025. Trend: 2023 $1,823 · 2024 $1,910 · 2025 $1,339
Food & beverage: $1,227Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 18 | $325 |
| Otsuka America Pharmaceutical, Inc. | 21 | $258 |
| E.R. Squibb & Sons, L.L.C. | 9 | $169 |
| Neurocrine BioSciences, Inc. | 5 | $153 |
| Axsome Therapeutics, Inc. | 4 | $78 |
| Janssen Pharmaceuticals, Inc | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| Alkermes, Inc. | 3 | $60 |
| Lundbeck LLC | 2 | $52 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
Products named: ABILIFY MAINTENA, COBENFY, INGREZZA, REXULTI, AUSTEDO XR, UZEDY, Auvelity, INVEGA.
Industry payments across FL — which companies pay providers there.
